Peptimmune

Peptimmune

closed
Drug company focused on the rare skin disease pemphigus vulgaris.

Employees
Market cap
-
Enterprise valuation
€32—49m (Dealroom.co estimates Jul 2008.)
Cambridge Massachusetts (HQ)
Authorizing premium user...